N-terminal HCV core protein fragment decreases 20S proteasome activity in the presence of PA28γ

Add time:08/30/2019    Source:sciencedirect.com

The Hepatitis C virus (HCV) core protein plays a crucial role in the development of chronic liver diseases such as chronic hepatitis, cirrhosis, and hepatocellular carcinoma (HCC). Its involvement in these diseases is reportedly abolished by a knockout of the proteasome activator PA28γ gene in transgenic mice, suggesting an interaction between the core protein and the PA28γ-proteasome system. This study found a direct interaction between the N-terminal 1–71 fragment of HCV core protein (Core71) and PA28γ in vitro, and that this interaction was found to enhance PA28γ-20S proteasome complex formation. While 20S proteasome activity was increased by PA28γ, it was significantly reduced by Core71 attachment in a dose-dependent manner. These results suggest that the Core-PA28γ interaction has an important role in regulating 20S proteasome activity and furthers our understanding of the pathogenesis of HCV.

We also recommend Trading Suppliers and Manufacturers of (20S)-N,N,N',N',4β,14-Hexamethyl-9,19-cyclo-5α-pregnane-3β,20-diamine (cas 19642-32-1). Pls Click Website Link as below: cas 19642-32-1 suppliers

Prev:Chapter Nine - Structural mass spectrometry approaches to study the 20S proteasome
Next:Research paperTheoretical study of the inhibition mechanism of human 20S proteasome by dihydroeponemycin)